Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48642
Campo DC Valoridioma
dc.contributor.authorCitores, M. J.en_US
dc.contributor.authorRua-Figueroa, I.en_US
dc.contributor.authorRodriguez-Gallego, C.en_US
dc.contributor.authorDurántez, A.en_US
dc.contributor.authorGarcía-Laorden, M. I.en_US
dc.contributor.authorRodríguez Lozano, C.en_US
dc.contributor.authorRodríguez-Pérez, J. C.en_US
dc.contributor.authorVargas, J. A.en_US
dc.contributor.authorPérez-Aciego, P.en_US
dc.contributor.otherGarcia-Laorden, M. Isabel-
dc.contributor.otherVargas, Juan Antonion-
dc.contributor.otherRodriguez-Perez, J.C.-
dc.date.accessioned2018-11-23T23:40:19Z-
dc.date.available2018-11-23T23:40:19Z-
dc.date.issued2004en_US
dc.identifier.issn0003-4967en_US
dc.identifier.urihttp://hdl.handle.net/10553/48642-
dc.description.abstractObjective: To investigate the association of the (CA)n dinucleotide repeat in the 3′ untranslated region (3′UTR) of the CD154 gene with systemic lupus erythematosus (SLE), and its functional role in protein expression. Methods: The allelic and genotypic distributions of the polymorphism were compared in 80 patients with SLE and 80 controls. A complete clinical and analytical database was recorded in each patient in order to correlate the clinical manifestations in SLE with different alleles. To investigate the functional role of the polymorphism, the CD154 protein expression on activated lymphocytes from healthy homozygous controls was evaluated by flow cytometry. Results: The 24 CA allele was the most represented in controls (p = 0.029), whereas the alleles containing >24 CA repeats were found in patients (p = 0.0043). Furthermore, when only homozygous women were considered, most controls carried two 24 CA alleles (p = 0.041), whereas most patients carried two alleles containing >24 CA repeats (p = 0.032). Also, patients carrying at least one 24 CA allele had less neurological involvement (p = 0.034), and carriers of at least one allele with fewer than 24 CA repeats presented more livedo reticularis (p = 0.006) and anti-Sm (p = 0.01) and anti-RNP (p = 0.038) autoantibodies. CD154 maximum expression in activated lymphocytes from all controls was reached after 54 hours, but it was more prolonged in controls carrying two alleles with >24 CA repeats (p = 0.0068). Conclusion: The CD154 3′UTR microsatellite is associated with SLE, and the most represented alleles in patients were accompanied by a more prolonged protein expression in activated lymphocytes from controls.en_US
dc.languageengen_US
dc.publisher0003-4967-
dc.relation.ispartofAnnals of the rheumatic diseasesen_US
dc.sourceAnnals of the Rheumatic Diseases[ISSN 0003-4967],v. 63, p. 310-317en_US
dc.subject3205 Medicina internaen_US
dc.titleThe dinucleotide repeat polymorphism in the 3′UTR of the CD154 qene has a functional role on protein expression and is associated with systemic lupus erythematosusen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1136/ard.2003.006148en_US
dc.identifier.scopus1342280432-
dc.identifier.isi000188896400020-
dcterms.isPartOfAnnals Of The Rheumatic Diseases-
dcterms.sourceAnnals Of The Rheumatic Diseases[ISSN 0003-4967],v. 63 (3), p. 310-317-
dc.contributor.authorscopusid6603293575-
dc.contributor.authorscopusid6602687781-
dc.contributor.authorscopusid6602114379-
dc.contributor.authorscopusid7004374118-
dc.contributor.authorscopusid6506073949-
dc.contributor.authorscopusid6603136298-
dc.contributor.authorscopusid7005446255-
dc.contributor.authorscopusid35554857000-
dc.contributor.authorscopusid6602739743-
dc.description.lastpage317en_US
dc.identifier.issue3-
dc.description.firstpage310en_US
dc.relation.volume63en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000188896400020-
dc.contributor.daisngid833956-
dc.contributor.daisngid401261-
dc.contributor.daisngid603384-
dc.contributor.daisngid667664-
dc.contributor.daisngid1683208-
dc.contributor.daisngid1048977-
dc.contributor.daisngid245684-
dc.contributor.daisngid319841-
dc.contributor.daisngid3713831-
dc.identifier.investigatorRIDB-3649-2019-
dc.identifier.investigatorRIDH-8933-2017-
dc.identifier.investigatorRIDC-1247-2010-
dc.utils.revisionen_US
dc.identifier.ulpgcNoen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr3,916
dc.description.jcrqQ1
dc.description.scieSCIE
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.deptGIR IUIBS: Patología y Tecnología médica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0002-4344-8644-
crisitem.author.orcid0000-0003-0023-1063-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameRodríguez Gallego, José Carlos-
crisitem.author.fullNameRodríguez Pérez,José Carlos-
Colección:Artículos
miniatura
Adobe PDF (371,88 kB)
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.